Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel Implant for Emergency Contraception
NCT06162611Phase 4Recruiting
- Start
- Nov 2023
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in emergency contraception (EC) comparing Etonogestrel implant + oral levonorgestrel with Etonogestrel implant + placebo (2 arms). Primary endpoints: Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraception at 1 month, Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraception by BMI category at 1 month and 4 more. Started Nov 2023; status: recruiting.
02
Drugs
etonogestrelavatrombopag
03
Conditions
emergency contraception (EC)
Beyond the preview
Go deeper on NCT06162611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162611.